Long-term survival of paediatric patients with pulmonary alveolar proteinosis treated with lung lavage [2]

European Respiratory Journal

Volumn 25, Issue 6, 2005, Pages 1127-

  Spock, A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ARTIFICIAL VENTILATION; BODY WEIGHT; CASE REPORT; ENDOTRACHEAL TUBE; HUMAN; HYPOXEMIA; INFANT; LETTER; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG LAVAGE; PATIENT POSITIONING; PRIORITY JOURNAL; SURVIVAL TIME; SYMPTOM; TREATMENT OUTCOME;

ADULT; BRONCHOALVEOLAR LAVAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; PULMONARY ALVEOLAR PROTEINOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20444507902     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00017605     Document Type: Letter

References (9)

1. Beccaria M, Luisetti M, Rodi G, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J 2004; 23: 526-531.
2. Morgan C. The benefits of whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J 2004; 23: 503-505.
3. Spock A, Lanning CF, Kylstra J. Lavage of both lungs of a nine month infant with alveolar proteinosis. Clin Res 1977; 25: 84.
4. Spock A, Lanning CF, Kylstra J, Comporesi E. Lung lavage in two infants with alveolar proteinosis. Pediatr Res 1983; 17: 390.
5. Kariman K, Spock A, Kylstra J. Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years. Lung 1984; 162: 223-231.
6. Spock A. Treatment of congenital alveolar proteinosis. J Pediatr 1993; 123: 495-496.
7. Spock A. Pulmonary alveolar proteinosis. Pediatrics 1997; 89: 756.
8. Muggenburg BA, Mauderly JL. Lung lavage using a single-lumen endotracheal tube. J Appl Physiol 1975; 38: 922-926.
9. Spock A. State of the art of lung lavage in patients with cystic fibrosis. In: Warwick WJ, ed. 1000 Years of Cystic Fibrosis. Minneapolis, University of Minnesota Press, 1981; pp. 113-117.